Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
出版年份 2020 全文链接
标题
Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
作者
关键词
-
出版物
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-03
DOI
10.1007/s10637-020-00925-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
- (2018) Edwin P. Hui et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
- (2018) Ting Jin et al. Translational Oncology
- Progress in the treatment of solid tumors with apatinib: a systematic review
- (2018) Deze Zhao et al. OncoTargets and Therapy
- The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis
- (2018) Dantong Sun et al. OncoTargets and Therapy
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment
- (2017) Ying Lin et al. TUMOR BIOLOGY
- Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
- (2017) Corey Smith et al. OncoImmunology
- Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study
- (2017) Yong Zhang et al. Scientific Reports
- A phase II study of apatinib, a highly selective inhibitor of VEGFR-2, in patients with metastatic solid tumors without standard treatment options
- (2016) Y-K. Kang et al. ANNALS OF ONCOLOGY
- Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward
- (2016) Lorenzo Fornaro et al. JOURNAL OF CLINICAL ONCOLOGY
- Apatinib in treatment of refractory gastric cancer
- (2016) Vicki Brower LANCET ONCOLOGY
- Individualized treatment in stage IVC nasopharyngeal carcinoma
- (2014) Oscar S.H. Chan et al. ORAL ONCOLOGY
- Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy
- (2013) Pei-Jian Peng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy
- (2013) Yan Gao et al. EXPERT OPINION ON PHARMACOTHERAPY
- A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
- (2011) Wan-Teck Lim et al. CLINICAL CANCER RESEARCH
- Inhibition of Vascular Endothelial Growth Factor Receptor Signal Transduction Blocks Follicle Progression but Does Not Necessarily Disrupt Vascular Development in Perinatal Rat Ovaries1
- (2009) Renee M. McFee et al. BIOLOGY OF REPRODUCTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started